Featured Jobs
|
Experienced Employee Benefits Attorney Shipman & Goodwin LLP
|
|
Daybright Financial
|
|
Independent Retirement
|
|
EPIC RPS
|
|
Director of Regulatory Operations and Compliance PCS Retirement
|
|
Relationship Manager – Defined Contributions Daybright Financial
|
|
Stones River Consulting
|
|
Regional Sales Director-Heartland July Business Services
|
|
EPIC RPS
|
|
Daybright Financial
|
|
Regional Sales Director-Mid Atlantic July Business Services
|
|
Internal Channel Sales Team Lead July Business Services
|
|
Nova 401(k) Associates
|
|
Spectrum Pension Consultants (part of Daybright Financial)
|
|
Director, Strategic Accounts and Channel Development July Business Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Weight Loss Drug Coverage Gets More Complicated
Becker's Healthcare 
June 3, 2024 "[A] federal lawmaker warned weight loss drugs have the potential to bankrupt the healthcare system, and new research from Blue Cross Blue Shield found nearly six in 10 patients taking the drugs don't reach a meaningful health benefit.... Weight loss medications such as Ozempic and Wegozy can cost upward of $10,000 a year. In 2022, Medicare spent $5.7 billion on the medications, up from $57 million in 2018 ... If half of Americans with obesity took weight loss drugs, it would cost $411 billion annually[.]" MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |